News Release Details

Luminex® Corporation (NASDAQ: LMNX) develops, manufactures, and markets proprietary biological testing technologies, with applications throughout the life-sciences industry.

Luminex Corporation to Present at 39th Annual J.P. Morgan Healthcare Conference

AUSTIN, Texas, Dec. 16, 2020 /PRNewswire/ -- Luminex Corporation (Nasdaq: LMNX) today announced that Nachum "Homi" Shamir, Chairman, CEO and President, and Harriss Currie, Senior Vice President and CFO, will present at the 39th Annual J.P. Morgan Healthcare Conference, to be held virtually, on January 13, 2021 at 3:30 p.m. Central Time.  A live webcast of the Luminex presentation may be accessed at the company's website at The presentation will be archived for six months on the website using the 'replay' link.

About Luminex Corporation 

At Luminex, our mission is to empower labs to obtain reliable, timely, and actionable answers, ultimately advancing health. We offer a wide range of solutions applicable in diverse markets including clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic and proteomic research, biodefense research, and food safety. We accelerate reliable answers while simplifying complexity and deliver certainty with a seamless experience. To learn more about Luminex, please visit us at

Harriss Currie
Senior Vice President and Chief Financial Officer
[email protected]

Carla Stanaford
Investor Relations
[email protected] 

Luminex logo. (PRNewsFoto/Luminex Corporation)


Cision View original content to download multimedia:

SOURCE Luminex Corporation

Shareholder Tools